The 2025 cough syrup tragedy, which claimed more than twenty three childrens lives, exposed serious gaps in Indias drug quality system. Despite new rules, advisories and updated testing methods, experts say these measures do not fully guarantee safety. Manufacturers warn of rising compliance costs, while labs say the impact on consumers will be small. The real issue is that unsafe medicines can still reach the market if rules are not enforced on the ground. This tragedy highlights why consumers must stay aware, question medicine quality and ask for test reports. Safe medicine should never depend on luck, and verified information is the only real protection until the system becomes stronger.